Rating History for Aktis Oncology (AKTS) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for AKTS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/19/2026 David Nierengarten New Coverage Outperform
(N/A)		 35.00
(N/A)		 25.00
(25.99)		 3.96% Details